Urgent.News

What's breaking now, across thousands of outlets.

Business

Prix littéraires : l’hégémonie de Gallimard fait grincer des dents dans l’édition

Le Goncourt, le Renaudot, le Femina et le Médicis ont couronné, en 2026, des auteurs de Madrigall, la maison mère de Gallimard, ce qui irrite les éditeurs concurrents, qui critiquent la composition des jurys.

Prix littéraires : l’hégémonie de Gallimard fait grincer des dents dans l’édition

We haven't written up this one. Le Monde Economie has the full story — the link below goes straight to it.

Read the original at lemonde.fr →

More in Business

Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story.

Bristol Myers Squibb is facing down the expiration of patent protections for older drugs, but new drugs are starting to show promise.

  • Bristol Myers Squibb's growth portfolio generates $7.7 billion quarterly.
  • Legacy portfolio's $4.69 billion comes from Eliquis, with patent expiring in 2028.
  • Dividend payout ratio of 55% with history of supporting dividends during challenges.

More from Saturday 14 November →